C–C chemokine receptors type 2 (CCR2) and 5 (CCR5) and their ligands CCL2 and CCL5 are implicated in the pathogenesis of liver inflammation and fibrosis, especially in NASH [35]. This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatohepatitis.